About this medicine

Dronabinol is a medicinal form of delta-9-tetrahydrocannabinol, usually called THC. THC is the substance in cannabis that can make a person feel high.

An unlicensed medicine can sometimes be considered for an individual patient. The prescriber needs to explain why a licensed alternative cannot meet that person’s needs, discuss benefits and risks, and arrange follow-up.

What is this medicine used for?

Marinol and Syndros are US product names. In the US, dronabinol has approved uses in adults for loss of appetite with weight loss due to AIDS, and for sickness from chemotherapy when usual anti-sickness medicines have not helped enough. These are US indications.

In the UK, NICE advises that a different medicine, nabilone, may be considered as an add-on for adults whose chemotherapy-related nausea and vomiting persist despite usual treatment. Dronabinol and nabilone have different active ingredients.

Which warning signs need help?

Call 999 for a first seizure or for severe breathing difficulty. If a seizure occurs while taking dronabinol, seek medical help straight away and do not take another dose until a clinician advises you.

Seek urgent medical advice if you faint, become severely confused, or start seeing or hearing things others do not. Contact your care team if abdominal pain or repeated vomiting develops or worsens, especially if you cannot keep fluids down.

How do I take it safely?

Marinol is a capsule and Syndros is an oral liquid in US labelling. The two products use different dosing instructions. If an unlicensed product is supplied in the UK, confirm its name, form, strength and directions with the dispensing pharmacist. For a liquid, ask them to show you how to measure the prescribed volume.

What side effects should I know about?

Some people experience sleepiness, anxiety, suspicious thoughts or difficulty concentrating. Tell the prescriber if these effects interfere with daily life. Avoid driving if you feel dizzy, drowsy or unable to concentrate.

Who needs extra care with this medicine?

Tell the prescriber about a history of mania, depression, psychosis, seizures, heart problems or drug dependence. The product information advises avoiding dronabinol where possible in people with a psychiatric history because symptoms can worsen.

Ingredients vary. Marinol capsules contain sesame oil and Syndros contains alcohol. Tell the pharmacist about any allergies so they can check the exact product.

Can it affect my other medicines?

Alcohol, opioid painkillers, sleeping tablets and some medicines for anxiety can increase drowsiness and slow reactions. Ask a pharmacist to check your medicines before taking them together.

The US Syndros liquid contains alcohol. Its label warns against disulfiram or metronidazole during treatment, in the 14 days before starting the liquid and for 7 days after the last dose. Speak to your prescriber promptly if you need either medicine.

What check-ups will I need?

Ask which symptom you and your prescriber will track, when you will check for improvement and whom to contact if a problem develops. Mention mood changes, faintness or sedation, even if the original symptom is improving. Anyone can report a suspected side effect through the MHRA Yellow Card scheme.

What about pregnancy, breastfeeding and age?

Product information advises avoiding dronabinol in pregnancy. If you are pregnant, planning a pregnancy or breastfeeding, speak with the prescriber about your circumstances. Older adults may be more sensitive to confusion or falls. The nightmare trial involved adults and does not establish benefit in children.

What if I miss a dose or want to stop?

Ask the pharmacist how to handle a missed dose for your product and treatment schedule. Avoid taking two doses together to catch up. After regular use, stopping suddenly can cause withdrawal symptoms, so discuss a plan with your prescriber.

How does it work?

The brain has receptors that respond to the body’s own cannabinoid signals. THC can activate these receptors, changing signals involved in appetite and nausea. The same action can affect attention, memory and how a person perceives their surroundings.

How does it affect my body?

Dronabinol can cause drowsiness, dizziness or a feeling of being high. It can change heart rate or blood pressure, and standing up suddenly may make you feel faint.

How does my body process it?

After you swallow dronabinol, the liver breaks it down. One of the resulting substances is active too. A meal can change how much medicine reaches the bloodstream, so ask the pharmacist how to take the exact product you have been given.

How do treatment options differ?

Nabilone is another cannabinoid with its own UK licence. Sativex is a mouth spray containing THC and CBD and has a separate indication for muscle stiffness in multiple sclerosis. A recommendation or licence for either product applies to that particular medicine.

A closer look at the science

Dronabinol is delta-9-THC. A product that also contains cannabidiol (CBD) has a different mix of active ingredients. One cannabis-based product cannot be substituted for another on the strength of the name alone.

How was this medicine developed?

Dronabinol was first approved in the US in 1985. Years later, researchers examined a different question: whether oral THC could ease recurrent nightmares in people with PTSD. The short-term results published in 2026 provide evidence about that symptom. UK licensing and guidance answer a separate question about how a medicine can be used in UK care.

What does the research say about PTSD nightmares?

A 2026 trial randomly assigned 171 adults with post-traumatic stress disorder (PTSD) and recurrent nightmares to dronabinol or a placebo for 10 weeks. On a scale from 0 to 8 measuring nightmare frequency and intensity, scores fell by about 3.7 points with dronabinol and 2.2 with placebo.

The trial did not show a clear improvement in overall PTSD symptoms. Seven people who received dronabinol had serious medical events, compared with none on placebo. Those figures alone do not establish what caused the events. Longer-term benefit and safety are uncertain.

NICE guidance for adults with PTSD includes trauma-focused cognitive behavioural therapy, which helps people process traumatic memories. Dronabinol has no UK licence for PTSD or nightmares.

Sources and References

  1. Cannabis-based products for medicinal use, section on synthetic cannabinoids
  2. Prescribers’ responsibilities when using unlicensed medicines

    Scope: United Kingdom.

  3. Prescribing unlicensed medicines
  4. Cannabis-based medicinal products, recommendations (NG144)
  5. Post-traumatic stress disorder, recommendations (NG116)
  6. Dronabinol for nightmares in post-traumatic stress disorder, randomised controlled trial (2026)
  7. Marinol capsule prescribing information (United States)
  8. Syndros oral solution prescribing information (United States)
  9. Dronabinol patient information (United States)
  10. What to do if someone has a seizure
  11. Report a problem with a medicine or medical device
  12. NIMH: Understanding psychosis

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top